NCT05053152 2026-04-08Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyNRG OncologyPhase 2 Active not recruiting194 enrolled
NCT05722925 2025-11-14Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETOHSU Knight Cancer InstitutePhase 4 Active not recruiting50 enrolled